Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:02 PM
Ignite Modification Date:
2025-12-24 @ 11:02 PM
NCT ID:
NCT01492569
Eligibility Criteria:
Inclusion Criteria:
* Patient with a planned admission for at least 24 hours for highly emetogenic or moderately emetogenic chemotherapy at Lucile Packard Children's Hospital or Packard El Camino.
* Planned to undergo at least 2 more cycles of chemotherapy.
* Can include but not limited to: children with high risk ALL, AML, Ewing's Sarcoma, Osteosarcoma
* History of vomiting with prior cycles of chemotherapy (2 episodes of emesis at minimum) despite use of conventional antiemetic medications.
* Age 8-21.
* Parent must be able to understand and willing to sign written informed consent document.
Exclusion Criteria:
* Prior knowledge of acupuncture or experience with acupuncture or acupressure.
* There will be no restrictions regarding use of other Investigational Agents.
* Comorbid Diseases:
* Diagnosis of any cardiac condition (cardiomyopathy, arrhythmia, pacemaker placement).
* Any diagnosis requiring pediatric intensive care unit admission.
* Patients with brain tumor, brain metastasis (these patients often require radiation and surgery in addition to chemotherapy which may confound the results)
* Concomitant radiation therapy during current chemotherapy cycle.
* Developmental delay patients with allergy to tape or leads will be excluded from the study.
* Pregnant patients will be excluded from the study.
* Cancer survivors will not be excluded from the study as long as they are undergoing chemotherapy treatment for their current cancer therapy.
* HIV-positive patients will not be excluded.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
8 Years
Maximum Age:
21 Years
Study:
NCT01492569
Study Brief:
Protocol Section:
NCT01492569